Lung Cancer
Conditions
Keywords
decision-support sheet
Brief summary
Observational two year study to evaluate the utility of a decision-support sheet on how to proceed in case of aggravation of a patient's condition with advanced disease.
Detailed description
Prospective and multicenter study conducted in the Rhône-Alpes-Auvergne area. All patients suffering from lung cancer admitted to a pulmonology unit in 2014 will be included. This document will be used if a decision to withhold life-sustaining treatment is decided. Investigators will assess the relationship between the planned intensity of care and those established when the patient develops an organ failure. Patient characteristics and factors associated with proposed levels and types of care will be analyzed. Patient and family opinions will be obtained after 3 months. The number of subjects is 468.
Interventions
OTHERobservational study
Sponsors
University Hospital, Grenoble
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Any patient with lung cancer, hospitalized in pulmonology unit in one of the participating centers. * Patient who requires a decision to withhold life-sustaining treatment * One patient can be included at each hospitalization.
Exclusion criteria
* Minor patient * Refusal of participation of the patient in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Emergent Serious Adverse Events | 1 year and a half | The main objective of this study is to assess the relationship between the planned intensity of care and those established when the patient develops organ failure. The agreement will be assessed using Cohen's kappa coefficient . |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient feeling assessment using phone interview questionnaire | 3 months after patient inclusion | Patients will be contacted by the investigator, to evaluate their feeling according to the collect of their opinion and wishes using a phone interview questionnaire within 30 minutes duration |
| Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 | first day | assessment at inclusion |
Countries
France
Outcome results
None listed